Markets
LLY Watch
Eli Lilly & Co
$773.65
$-47.43 -5.77%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
36d agoSwungBullish
down -1.46% At 797.6, Now 785.9
With the projected rise in cefuroxime prices due to supply chain disruptions and tariffs, I believe Eli Lilly stands to benefit significantly. Their s... Read More
Goldman
@goldman_...
59.4% Winrate 1.2% Avg Gain 24.7% S&P Beat
Bought LLY Shares
36d agoSwungBullish
down -7.32% At 848.0, Now 785.9
Given Eli Lilly's successful phase 3 trial for its oral weight loss drug orforglipron and strong revenue growth from its diabetes and weight-loss drug... Read More
HSBC
@hsbc
50.0% Winrate 37.8% Avg Gain 567.3% S&P Beat
Shorted LLY Shares
39d agoSwungBearish
up 5.74% At 871.5, Exited 821.5
Given the impressive results of Eli Lilly's oral GLP-1 drug orforglipron in recent trials and its potential to capture market share from competitors, ... Read More
Exited 32d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought LLY Calls
42d agoSwungBullish
down -85.24% At 0.41, Exited 0.06
Contract: 960 Strike Call for Apr 25
I’m looking at LLY calls because this earnings week is stacked, and I believe LLY has strong potential to outperform, especially with their consistent... Read More
Exited 42d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
47d agoInvestedBullish
down -6.93% At 844.4, Now 785.9
With the Trump administration evaluating pharmaceutical tariffs, I believe Lilly's significant investment in US manufacturing will position it to bene... Read More
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
50d agoSwungBullish
up 3.18% At 833.2, Exited 859.7
With the promising results from the weight-loss pill trial, I'm confident that Eli Lilly's stock is set to rise further. It looks like they're on trac... Read More
Exited 43d ago
0 0
Saif
@oilking
15.0% Winrate 2.5% Avg Gain -338.5% S&P Beat
Bought LLY Puts
53d agoDaytradedBearish
down -99.87% At 15.69, Now 0.02
Contract: 737.5 Strike Put for Apr 17
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought LLY Calls
93d agoSwungBullish
down -53.5% At 26.93, Exited 12.52
Contract: 1000 Strike Call for May 16
I'm super bullish on LLY with two major catalysts coming up—the court ruling on the OFA v. FDA case and the Phase 3 data for Orforglipron. These could... Read More
Exited 88d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
100d agoSwungBullish
up 2.18% At 909.9, Exited 929.7
I just learned that Eli Lilly is pouring at least $27 billion into U.S. manufacturing, which is a huge bet on the future of their drug pipeline. With ... Read More
Exited 93d ago
0 0
Remzztrades
@remzztra...
13.4% Winrate -23.0% Avg Gain -714.9% S&P Beat
Bought LLY Calls
105d agoDaytradedBullish
down -99.46% At 1.85, Now 0.01
Contract: 1000 Strike Call for Mar 21
Close to a huge breakout
Posted 112d ago 1.54% Swung Bullish Exited
FUDSTOP
@www.fuds...
85.3% Winrate 46.2% Avg Gain 308.9% S&P Beat
SYMB Locked Data
112d agoSwung Exited 112d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
smartertrader
@smartert...
44.7% Winrate 54.2% Avg Gain 180.0% S&P Beat
Bought LLY Shares
116d agoDaytradedBullish
up 0.98% At 864.5, Exited 873.0
Exited 114d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
119d agoSwungBullish
down -4.34% At 882.6, Exited 844.3
I'm holding onto my 200 shares of LLY, and I'm seriously thinking about increasing my position to 400. With their strong pipeline, especially the pote... Read More
Exited 112d ago
0 0
smartertrader
@smartert...
44.7% Winrate 54.2% Avg Gain 180.0% S&P Beat
Bought LLY Shares
120d agoDaytradedBullish
down -0.07% At 869.5, Exited 868.9
Exited 116d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought LLY Shares
122d agoSwungBullish
up 6.33% At 813.5, Exited 865.0
I believe Eli Lilly is set to rise in the upcoming months due to the anticipated recovery from its recent supply issues with Trizepitide. Despite some... Read More
Exited 115d ago
0 0
Posted 127d ago 178% Daytraded Bullish Exited
coco
@coco.cub...
54.8% Winrate 18.4% Avg Gain 317.3% S&P Beat
SYMB Locked Data
127d agoDaytraded Exited 127d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Posted 129d ago 27.52% Swung Bullish Exited
Shashi
@shashiku...
54.5% Winrate 33.4% Avg Gain 155.9% S&P Beat
SYMB Locked Data
129d agoSwung Exited 127d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Trims & Adds [ ] Made $25.0K in profit
[-] 127d ago
All out @ 28.90
[+] 129d ago
Added 20.00 contracts @ 20.61
[+] 129d ago
Added 10.00 contracts @ 23.23
[+] 129d ago
Initial 10.00 contracts @ 26.20
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought LLY Puts
134d agoSwungBearish
down -60.09% At 9.08, Exited 3.62
Contract: 755 Strike Put for Jan 24
I see a significant pullback coming for LLY in the next couple of quarters due to production delays while they ramp up new factories. There's a strong... Read More
Exited 134d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
139d agoSwungBullish
up 11.0% At 728.0, Exited 808.2
I recently bought into LLY after they revised their Q4 forecast downward, creating a potential entry opportunity. The market sentiment seems bearish, ... Read More
Exited 130d ago
0 0
itrader001
@itrader0...
56.4% Winrate 5.4% Avg Gain 58.4% S&P Beat
Bought LLY Calls
143d agoInvestedBullish
up 23.86% At 91.85, Exited 113.77
Contract: 800 Strike Call for Jan 16, 26
Exited 130d ago
0 0
Posted 144d ago -81.09% Swung Bullish Exited
Shashi
@shashiku...
54.5% Winrate 33.4% Avg Gain 155.9% S&P Beat
SYMB Locked Data
144d agoSwung Exited 143d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
146d agoSwungBullish
down -9.17% At 799.0, Exited 725.7
I'm feeling bullish on Eli Lilly because their partnership with a prominent Silicon Valley VC firm indicates a commitment to innovation in biotech. In... Read More
Exited 137d ago
0 0
Remzztrades
@remzztra...
13.4% Winrate -23.0% Avg Gain -714.9% S&P Beat
Bought LLY Calls
147d agoSwungBullish
down -99.17% At 1.21, Now 0.01
Contract: 850 Strike Call for Jan 17
Posted 147d ago -89.84% Swung Bullish Exited
Shashi
@shashiku...
54.5% Winrate 33.4% Avg Gain 155.9% S&P Beat
SYMB Locked Data
147d agoSwung Exited 143d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Trims & Adds [ ] Lost $24.8K on the trade
[-] 143d ago
All out @ 0.93
[+] 144d ago
Added 20.00 contracts @ 7.85
[+] 147d ago
Initial 10.00 contracts @ 11.87
Posted 150d ago 36.77% Swung Bullish Exited
Shashi
@shashiku...
54.5% Winrate 33.4% Avg Gain 155.9% S&P Beat
SYMB Locked Data
150d agoSwung Exited 147d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Long
@long_gam...
45.9% Winrate 15.1% Avg Gain 135.0% S&P Beat
Bought LLY Shares
153d agoInvestedBullish
down -5.7% At 782.9, Exited 738.2
I’m super confident that Eli Lilly is going to be the clear market winner in the GLP1 space. With their strong positioning and product difference, I t... Read More
Exited 63d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
160d agoSwungBullish
down -2.27% At 782.9, Exited 765.1
With the recent news about the Zepbound shortage being over, I feel positive about LLY's potential to rebound. This could mean increased interest in E... Read More
Exited 151d ago
0 0
The
@themarke...
45.8% Winrate 60.8% Avg Gain 396.5% S&P Beat
Bought LLY Shares
160d agoSwungBullish
down -2.27% At 782.9, Exited 765.1
I’m planning on buying LLY because there's strong momentum in pharma right now, and I believe it's set to perform well in the near term. Holding share... Read More
Exited 151d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought LLY Shares
167d agoSwungBullish
down -0.77% At 779.8, Exited 773.8
Given the recent approval of Eli Lilly’s weight-loss drug for sleep apnea and the positive sentiment around its potential, I'm riding the bullish tren... Read More
Exited 158d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought LLY Shares
169d agoSwungBullish
up 3.25% At 758.5, Exited 783.2
I'm all in on Eli Lilly here. The FDA is shutting down competing pharmacies, and with their upcoming expansions and solid drug pipeline, I see a massi... Read More
Exited 161d ago
0 0
Sign in or create an account Get notifications, save trades, and more
google logo Continue with Google Continue with Email
By continuing, you agree to our Terms and Privacy Policy.